These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30963978)

  • 1. Visfatin and Rheumatoid Arthritis: Pathogenetic Implications and Clinical Utility.
    Polyakova YV; Zavodovsky BV; Sivordova LE; Akhverdyan YR; Zborovskaya IA
    Curr Rheumatol Rev; 2020; 16(3):224-239. PubMed ID: 30963978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin as a therapeutic target for rheumatoid arthritis.
    Franco-Trepat E; Alonso-Pérez A; Guillán-Fresco M; Jorge-Mora A; Gualillo O; Gómez-Reino JJ; Gómez Bahamonde R
    Expert Opin Ther Targets; 2019 Jul; 23(7):607-618. PubMed ID: 31074669
    [No Abstract]   [Full Text] [Related]  

  • 3. PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis?
    Nowell M; Evans L; Williams A
    Future Med Chem; 2012 Apr; 4(6):751-69. PubMed ID: 22530639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.
    Gonzalez-Gay MA; Vazquez-Rodriguez TR; Garcia-Unzueta MT; Berja A; Miranda-Filloy JA; de Matias JM; Gonzalez-Juanatey C; Llorca J
    Clin Exp Rheumatol; 2010; 28(1):56-62. PubMed ID: 20346239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin: a potential therapeutic target for rheumatoid arthritis.
    Bao JP; Chen WP; Wu LD
    J Int Med Res; 2009; 37(6):1655-61. PubMed ID: 20146863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
    Présumey J; Courties G; Louis-Plence P; Escriou V; Scherman D; Pers YM; Yssel H; Pène J; Kyburz D; Gay S; Jorgensen C; Apparailly F
    Ann Rheum Dis; 2013 Oct; 72(10):1717-24. PubMed ID: 23313810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity.
    Stofkova A
    Endocr Regul; 2010 Jan; 44(1):25-36. PubMed ID: 20151765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond fat mass: exploring the role of adipokines in rheumatic diseases.
    Scotece M; Conde J; Gómez R; López V; Lago F; Gómez-Reino JJ; Gualillo O
    ScientificWorldJournal; 2011; 11():1932-47. PubMed ID: 22194660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network.
    Kontny E; Plebanczyk M; Lisowska B; Olszewska M; Maldyk P; Maslinski W
    Ann Rheum Dis; 2012 Feb; 71(2):262-7. PubMed ID: 21989538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis.
    Straburzyńska-Lupa A; Nowak A; Pilaczyńska-Szcześniak Ł; Straburzyńska-Migaj E; Romanowski W; Karolkiewicz J; Sliwicka E
    Clin Exp Rheumatol; 2010; 28(1):19-24. PubMed ID: 20346233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities.
    Brentano F; Schorr O; Ospelt C; Stanczyk J; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2007 Sep; 56(9):2829-39. PubMed ID: 17763446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle.
    Cirillo P; Di Palma V; Maresca F; Pacifico F; Ziviello F; Bevilacqua M; Trimarco B; Leonardi A; Chiariello M
    Thromb Res; 2012 Sep; 130(3):403-8. PubMed ID: 22726553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis.
    Lee YH; Bae SC
    Int J Rheum Dis; 2018 Mar; 21(3):664-672. PubMed ID: 28205390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases.
    Dakroub A; Nasser SA; Kobeissy F; Yassine HM; Orekhov A; Sharifi-Rad J; Iratni R; El-Yazbi AF; Eid AH
    J Cell Physiol; 2021 Sep; 236(9):6282-6296. PubMed ID: 33634486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines in rheumatoid arthritis.
    Fatel ECS; Rosa FT; Simão ANC; Dichi I
    Adv Rheumatol; 2018 Aug; 58(1):25. PubMed ID: 30657068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesfatin-1 and visfatin expression is associated with reduced atherosclerotic disease risk in patients with rheumatoid arthritis.
    Robinson C; Tsang L; Solomon A; Woodiwiss AJ; Gunter S; Mer M; Hsu HC; Gomes M; Norton GR; Millen AME; Dessein PH
    Peptides; 2018 Apr; 102():31-37. PubMed ID: 29475075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin as a novel mediator released by inflamed human endothelial cells.
    Romacho T; Villalobos LA; Cercas E; Carraro R; Sánchez-Ferrer CF; Peiró C
    PLoS One; 2013; 8(10):e78283. PubMed ID: 24130902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAMPT Is an Essential Regulator of RA-Mediated Periodontal Inflammation.
    Kim D; Lee G; Huh YH; Lee SY; Park KH; Kim S; Kim J; Koh J; Ryu J
    J Dent Res; 2017 Jun; 96(6):703-711. PubMed ID: 28165872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial Cells.
    Hasseli R; Frommer KW; Schwarz M; Hülser ML; Schreiyäck C; Arnold M; Diller M; Tarner IH; Lange U; Pons-Kühnemann J; Schönburg M; Rehart S; Müller-Ladner U; Neumann E
    Front Immunol; 2020; 11():925. PubMed ID: 32582145
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort.
    Sglunda O; Mann H; Hulejová H; Kuklová M; Pecha O; Pleštilová L; Filková M; Pavelka K; Vencovský J; Senolt L
    PLoS One; 2014; 9(7):e103495. PubMed ID: 25068448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.